Dermoestetica "buy"

01/02/07 - Ibersecurities

LONDON, January 1 (newratings.com) - Analysts at Ibersecurities maintain their "buy" rating on Dermoestetica (DERM). The target price is set to €9.10.

In a research note published this morning, the analysts mention that the company has announced its intention of going ahead with its 5% share buyback programme. Dermoestetica is unlikely to spend more than €16.91 million, given the company’s current share price and the repurchase of just 5% shares, Ibersecurities adds.